Lupin recalls over 600,000 bottles of hypertension drug in US: USFDA

Q: How long will it take to read this news story?

The story "Lupin recalls over 600,000 bottles of hypertension drug in US: USFDA" has 408 words across 15 sentences, which will take approximately 2 - 4 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Lupin recalls over 600,000 bottles of hypertension drug in US: USFDA" was covered 5 hours ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 327 news stories per day. It's most recent story was published 2 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #23834745</li><li>URL: https://beamstart.com/news/lupin-recalls-over-600000-bottles-17325477411792</li></ul>

Business Standard Logo Business Standard 5h ago

Lupin recalls over 600,000 bottles of hypertension drug in US: USFDA - Business Standard

Quick Summary:

Drug firm Lupin is recalling over six lakh bottles of a medication indicated for high blood pressure in the US due to deviation from current good manufacturing practices (CGMP), according to the US health regulator.

Baltimore-based Lupin Pharmaceuticals Inc, a subsidiary of Mumbai-based Lupin, is recalling 6,16,506 bottles of Ramipril capsules in strengths of 2.5 mg, 5 mg and 10 mg, the US health regulator said.

As per its latest Enforcement Report, US Food and Drug Administration (USFDA), stated that Dr Reddy's Laboratoties is also recalling a product in the US due to a manufacturing issue.